Director Clinical Development (f/m/x)

Passion for Innovation. Compassion for Patients.

With over 120 years of experience and more than 17,000 employees in over 20 countries, Daiichi Sankyo is dedicated to discovering, developing, and delivering new standards of care that enrich the quality of life around the world. In Europe, we focus on two areas: The goal of our Specialty Business is to protect people from cardiovascular disease, the leading cause of death in Europe, and help patients who suffer from it to enjoy every precious moment of life. In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel therapies for people with cancer. Our European headquarters are in Munich, Germany, and we have affiliates in 13 European countries and Canada.

We are seeking highly qualified candidates to fill the position:

Director Clinical Development (f/m/x)

The Position:

Oversees one or more trials of medium to high complexity in design and geographic scope. Such trials could be pivotal for submission; Prepares clinical section of regulatory documents; Oversees management and performance of CRO; Participates in creation of developmental and regulatory strategy; Drafts protocol profiles and sections of key submission documents; Point of contact for interactions with regulatory-agency clinical reviewing divisions on clinical matters; Represents Clinical Development in Project Teams, possibly as Global Clinical Lead. The position can be filled Europe-wide.

Roles & Responsibilities:

• Study Strategy: Clinical study leader (CSL) or major scientific/medical contributor; For large or complex Phase 2 studies: Provides the strategic direction to BD&O for EDC, edit checks, data quality listings, SAP, DM plan, Reviews patient population and protocol compliance for consistency with study strategy, Develops biomarker strategy in collaboration with TMCP, Collaborates with external KOLs to refine study plans; Prepares and participate in regulatory agency meetings, if applicable
• Study planning and execution: As CSL for Phase 2 studies: Provides input on major milestones of trial, clinical trial plan and contingency planning, Analyzes, updates management on potential risks to study deliverables, Provides input on ICF creation, Oversees recruitment, retention; establishes and implement contingency plans for shortfalls, Consults & recruits members for DSMB and/or adjudication committee setup; Interacts with KOLs and PIs to plan study and monitor completion
• Study outputs: For Phase 2 studies: Drafts responses to IRBs and HA, Collaborates with TMCP to ensure appropriate biomarker, PK / PD measurements, Reviews emerging clinical data regularly, Leads dose-escalation meetings, Performs quality assessment with delivery lead e.g. review TLG before DBL, and quality check of data, Works with BD&O to ensure SAP updates; Responsible for valid clinical interpretation of study results as Clinical Study Leader, medical monitor or regional clinical/Translational Medicine and Clinical Pharmacology representative
• External collaboration: Develops and leads external advisory panels to advise on Phase 2 study strategy, design, and conduct; Interacts with KOLs for indication specific advice; Leads broad collaboration with KOLs or major institution, e.g. NCI.
• Scientific, Program related: Integrated Study Team (IST) representative: Creates early development plan and contributes to overall development Strategy; Develops program biomarker strategy; Achieves endorsement for plan by function and team; Interprets and react accordingly to new preclinical/clinical data(e.g.; Go/No Go decisions, reprioritization, etc.); Operational Project Team (OPT) leader; Responsible before the IST for the creation and execution of development strategy for a program
• Additional non-study related activities: Initiates contact w/KOL and prepare material for KOL interactions on a program-based need; Peripheral involvement in Business Development activities for late stage compounds Involvement with in-licensing and acquisitions on individual due diligence activities; Contributor to portfolio decisions

Education & Professional Experience:

• Master's Degree or equivalent preferred
• PharmD or equivalent preferred
• PhD or equivalent preferred
• 5 or More Years    with PharmD, PhD and relevant clinical experience preferred
• 7 or More Years    with Master’s degree and relevant clinical experience preferred
• Strategic Thinking
• Clinical Trials Knowledge
• Influencing Skills
• Scientific Knowledge
• Therapeutic Expertise
• Drug Development
• Critical Thinking
• Team Leadership
• Ability to travel up to 30%

Why work with us?

Working at Daiichi Sankyo is more than just a job – it is your chance to make a difference and change patients’ lives for the better. We can only achieve this ambitious goal together. That is why we foster a culture of mutual respect and continuous learning, with a strong commitment to inclusion and diversity. Here, you will have the opportunity to grow, think boldly, and contribute your ideas. If you have a proactive mindset and passion for addressing the needs of patients, we eagerly await your application.

For more information: www.daiichi-sankyo.de